Skye Bioscience Cash from Financing (TTM) Analysis

Skye Bioscience Inc (SKYE)

12.78 -0.15 (-1.16%) USD | NASDAQ | May 01, 16:00

12.64 -0.14 (-1.10%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	16.44M
September 30, 2023	16.50M
June 30, 2023	-0.2264M
March 31, 2023	-0.1948M
December 31, 2022	-0.2088M
September 30, 2022	-0.3267M
June 30, 2022	7.182M
March 31, 2022	8.978M
December 31, 2021	13.08M
September 30, 2021	13.20M
June 30, 2021	11.88M
March 31, 2021	10.74M
December 31, 2020	6.701M
September 30, 2020	8.677M
June 30, 2020	2.581M
March 31, 2020	2.014M
December 31, 2019	6.005M
September 30, 2019	5.800M
June 30, 2019	5.800M
March 31, 2019	5.792M
December 31, 2018	5.541M

Date	Value
September 30, 2018	6.113M
June 30, 2018	6.113M
March 31, 2018	6.121M
December 31, 2017	3.513M
September 30, 2017	1.540M
June 30, 2017	1.540M
March 31, 2017	1.540M
December 31, 2016	0.4077M
September 30, 2016	-0.0079M
June 30, 2016	5.030M
March 31, 2016	6.023M
December 31, 2015	6.744M
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
July 31, 2014	0.0716M
April 30, 2014	0.0106M
January 31, 2014	0.02M
October 31, 2013	0.0784M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.3267M

Minimum

Sep 2022

16.50M

Maximum

Sep 2023

7.086M

Average

6.701M

Median

Dec 2020

Cash from Financing (TTM) Benchmarks